Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | NPC1 | O15118 | 3/20 | 0.58 |
| ▸ | RAB9A | P51151 | 3/20 | 0.58 |
| ▸ | CASP3 | P42574 | 2/20 | 0.58 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.58 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.58 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.58 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.58 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.58 |
| ▸ | RELA | Q04206 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.58 |
| ▸ | ATM | Q13315 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3420308 | 0.93 | ALDH1A1 (0.58) | ALDH1A1NPC1RAB9ACASP3SENP8 | |
| SCHEMBL31437680 | 0.93 | ALDH1A1 (0.58) | ALDH1A1NPC1RAB9ACASP3SENP8 | |
| SCHEMBL10614062 | 0.82 | ALDH1A1 (0.58) | ALDH1A1NPC1RAB9ACASP3SENP8 | |
| SCHEMBL16656174 | 0.82 | ALDH1A1 (0.58) | ALDH1A1NPC1RAB9ACASP3SENP8 | |
| SCHEMBL29926163 | 0.78 | ALDH1A1 (0.80) | ALDH1A1NPC1RAB9ACASP3SENP8 | |
| SCHEMBL22871158 | 0.78 | ALDH1A1 (0.73) | ALDH1A1NPC1RAB9ACASP3SENP8 | |
| SCHEMBL31472800 | 0.78 | ALDH1A1 (0.73) | ALDH1A1NPC1RAB9ACASP3SENP8 | |
| SCHEMBL7930867 | 0.78 | ALDH1A1 (0.80) | ALDH1A1NPC1RAB9ACASP3SENP8 | |
| SCHEMBL13433263 | 0.78 | NPC1 (0.88) | ALDH1A1NPC1RAB9ACASP3SENP8 | |
| SCHEMBL5724160 | 0.78 | NPC1 (0.88) | ALDH1A1NPC1RAB9ACASP3SENP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110776866-A | Sealing agent for electronic component, and liquid crystal display unit | 日本化药株式会社 | 2020-02-11 | — | — | CN | disclosed |
| EP-2968219-B1 | NOVEL THERAPY FOR PROSTATE CARCINOMA | PELLFICURE PHARMACEUTICALS INC (US) | 2019-04-24 | — | — | EP | disclosed |
| EP-2968219-B1 | NOVEL THERAPY FOR PROSTATE CARCINOMA | PELLFICURE PHARMACEUTICALS INC (US) | 2019-04-24 | — | — | EP | disclosed |
| US-10245240-B2 | Treatment of prostate carcinoma | PELLFICURE PHARMACEUTICALS, INC. (US) | 2019-04-02 | — | — | US | disclosed |
| US-10245240-B2 | Treatment of prostate carcinoma | PELLFICURE PHARMACEUTICALS, INC. (US) | 2019-04-02 | — | — | US | disclosed |
| US-20180296500-A1 | NOVEL TREATMENT OF PROSTATE CARCINOMA | PELLFICURE PHARMACEUTICALS, INC. | 2018-10-18 | — | — | US | disclosed |
| US-20180116977-A1 | NOVEL TREATMENT OF PROSTATE CARCINOMA | PELLFICURE PHARMACEUTICALS, INC. | 2018-05-03 | — | — | US | disclosed |
| US-20180116977-A1 | NOVEL TREATMENT OF PROSTATE CARCINOMA | PELLFICURE PHARMACEUTICALS, INC. | 2018-05-03 | — | — | US | disclosed |
| US-9877932-B2 | Treatment of prostate carcinoma | PELLFICURE PHARMACEUTICALS, INC. (US) | 2018-01-30 | — | — | US | disclosed |
| US-9877932-B2 | Treatment of prostate carcinoma | PELLFICURE PHARMACEUTICALS, INC. (US) | 2018-01-30 | — | — | US | disclosed |
| WO-2014158875-A1 | NOVEL THERAPY FOR PROSTATE CARCINOMA | PELLFICURE PHARMACEUTICALS INC. (US) | 2014-10-02 | — | — | WO | disclosed |
| US-20130219528-A1 | NOVEL TREATMENT OF PROSTATE CARCINOMA | PELLFICURE PHARMACEUTICALS, INC. (US) | 2013-08-22 | — | — | US | disclosed |
| US-20130219528-A1 | NOVEL TREATMENT OF PROSTATE CARCINOMA | PELLFICURE PHARMACEUTICALS, INC. (US) | 2013-08-22 | — | — | US | disclosed |
| US-20130219528-A1 | NOVEL TREATMENT OF PROSTATE CARCINOMA | PELLFICURE PHARMACEUTICALS, INC. (US) | 2013-08-22 | — | — | US | disclosed |
| WO-2012018948-A2 | NOVEL TREATMENT OF PROSTATE CARCINOMA | PELLFICURE PHARMACEUTICALS, INC. (US) | 2012-02-09 | — | — | WO | disclosed |
| US-20100129723-A1 | NON-AQUEOUS ELECTROLYTE FOR PRIMARY BATTERY, AND NON-AQUEOUS ELECTROLYTE PRIMARY BATTERY USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2010-05-27 | — | — | US | disclosed |
| CN-101263622-A | Non-aqueous electrolyte for primary battery and non-aqueous electrolyte primary battery using the same | MITSUBISHI CHEM CORP (JP) | 2008-09-10 | — | — | CN | disclosed |
| EP-1933404-A1 | NON-AQUEOUS ELECTROLYTE FOR PRIMARY BATTERY, AND NON-AQUEOUS ELECTROLYTE PRIMARY BATTERY USING THE SAME | Mitsubishi Chemical Corporation (JP) | 2008-06-18 | — | — | EP | disclosed |
| WO-2006107827-A1 | SKIN BONDING PROCESS | CREIGHTON UNIVERSITY (US) | 2006-10-12 | — | — | WO | disclosed |
| US-4184874-A | Photosensitive composition containing chelate compound | FUJI PHOTO FILM CO., LTD. (JP) | 1980-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130219528-A1 | NOVEL TREATMENT OF PROSTATE CARCINOMA | KLK3, AR, PLK1 | ALDH1A1 347/4885NPC1 1383/4885RAB9A 2258/4885 |
| US-10245240-B2 | Treatment of prostate carcinoma | KLK3, ACP3, PLK1 | ALDH1A1 320/4885NPC1 1227/4885RAB9A 2173/4885 |
| US-20180296500-A1 | NOVEL TREATMENT OF PROSTATE CARCINOMA | KLK3, AR, PLK1 | ALDH1A1 347/4885NPC1 1383/4885RAB9A 2258/4885 |
| US-20180116977-A1 | NOVEL TREATMENT OF PROSTATE CARCINOMA | KLK3, AR, PLK1 | ALDH1A1 347/4885NPC1 1383/4885RAB9A 2258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.